Mesoblast (MESO) Return on Equity (2017 - 2024)
Historic Return on Equity for Mesoblast (MESO) over the last 8 years, with Q4 2024 value amounting to 0.05%.
- Mesoblast's Return on Equity rose 800.0% to 0.05% in Q4 2024 from the same period last year, while for Dec 2024 it was 0.05%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.18% for FY2024, which is 200.0% down from last year.
- As of Q4 2024, Mesoblast's Return on Equity stood at 0.05%, which was up 800.0% from 0.08% recorded in Q2 2024.
- Over the past 5 years, Mesoblast's Return on Equity peaked at 0.05% during Q4 2024, and registered a low of 0.18% during Q2 2022.
- For the 5-year period, Mesoblast's Return on Equity averaged around 0.15%, with its median value being 0.17% (2020).
- Per our database at Business Quant, Mesoblast's Return on Equity tumbled by -200bps in 2021 and then soared by 800bps in 2024.
- Mesoblast's Return on Equity (Quarter) stood at 0.17% in 2020, then dropped by -2bps to 0.18% in 2021, then increased by 6bps to 0.17% in 2022, then rose by 22bps to 0.13% in 2023, then skyrocketed by 64bps to 0.05% in 2024.
- Its Return on Equity stands at 0.05% for Q4 2024, versus 0.08% for Q2 2024 and 0.13% for Q4 2023.